1 |
Cross RK, Finkelstein J. Feasibility and acceptance of a home telemanagement system in patients with inflammatory bowel disease: a 6-month pilot study. Dig Dis Sci 2007;52:357-364.
DOI
|
2 |
Cross RK, Arora M, Finkelstein J. Acceptance of telemanagement is high in patients with inflammatory bowel disease. J Clin Gastroenterol 2006;40:200-208.
DOI
|
3 |
Jackson BD, Gray K, Knowles SR, De Cruz P. EHealth technologies in inflammatory bowel disease: a systematic review. J Crohns Colitis 2016;10:1103-1121.
DOI
|
4 |
Kim ES, Lee YJ, Jang BI, et al. Disparity in Crohn's disease activity between home and clinics is associated with unscheduled hospital visits due to disease flares. Korean J Intern Med 2018;33:902-910.
DOI
|
5 |
Elkjaer M, Shuhaibar M, Burisch J, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach. Gut 2010;59:1652-1661.
DOI
|
6 |
Heida A, Dijkstra A, Muller Kobold A, et al. Efficacy of home telemonitoring versus conventional follow-up: a randomized controlled trial among teenagers with inflammatory bowel disease. J Crohns Colitis 2018;12:432-441.
DOI
|
7 |
Cross RK, Kane S. Integration of telemedicine into clinical gastroenterology and hepatology practice. Clin Gastroenterol Hepatol 2017;15:175-181.
DOI
|
8 |
Aguas Peris M, Del Hoyo J, Bebia P, et al. Telemedicine in inflammatory bowel disease: opportunities and approaches. Inflamm Bowel Dis 2015;21:392-399.
DOI
|
9 |
Patil SA, Cross RK. Current landscape of telemedicine practice in inflammatory bowel disease. Inflamm Bowel Dis 2018;24:1910-1917.
DOI
|
10 |
Chan W, Chen A, Tiao D, Selinger C, Leong R. Medication adherence in inflammatory bowel disease. Intest Res 2017;15:434-445.
DOI
|